Serotonin syndrome and concomitant use of tramadol and metoclopramide

被引:0
|
作者
Khatoon, Humera [1 ]
Muzammil, Mehreen
Sarfaraz, Sana
Jamil, Subia
Anser, Humera
机构
[1] Jinnah Univ Women, Fac Pharm, Karachi, Pakistan
来源
RAWAL MEDICAL JOURNAL | 2018年 / 43卷 / 04期
关键词
Concomitant use; metoclopramide; serotonin syndrome; tramadol;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify drug combinations with serotonergic potential and help clinicians to avoid combined use of serotonin-augmenting drugs. Methodology: This experimental study was conducted on thirty Wistar albino mice, divided into 3 equal groups (I, II, III) treated with distilled water, tramadol+metoclopramide and tramadol only bid for 15 days. Animal behavior, exploratory and locomotor activity were checked using sticky label, novel object and open filed tests. Results were analyzed by two-way ANOVA followed by Scheffe test. Results: Difference in animal behavior was significant with respect to rearing (p?0.01, p?0.001), freezing (p?0.001, p?0.05) and grooming (p?0.01, p?0.001) when group II was compared with I and III, respectively. Difference was also significant (p?0.001) when group III was compared with I. In open field test, animals of II and III groups showed hyperlocomotion (p?0.001) when compared with group I. Difference between II and III was also significant (p?0.001). In novelty-based tests (novel object and sticky label test), animals showed high level of vigilance (p?0.001) in groups II and III as compared to group I. Conclusion: Identification of serotonin-enhancing drugs and combinations is important to ensure patient safety. Animals can act as useful models for such identification.
引用
收藏
页码:738 / 742
页数:5
相关论文
共 50 条
  • [31] Serotonin syndrome attributed to tramadol and iproniazide coadministration
    de Larquier, A
    Vial, T
    Bréjoux, G
    Descotes, J
    THERAPIE, 1999, 54 (06): : 767 - 768
  • [32] Tramadol: Distinguishing the Pathophysiology of Serotonin Syndrome and Seizures
    Megarbane, Bruno
    Lagard, Camille
    Chevillard, Lucie
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (11): : E487 - E487
  • [33] Serotonin syndrome following the administration of tramadol with paroxetine
    Lantz, MS
    Buchalter, EN
    Giambanco, V
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1998, 13 (05) : 343 - 345
  • [34] Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures
    Hassamal, Sameer
    Miotto, Karen
    Dale, William
    Danovitch, Itai
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (11): : 1382.e1 - 1382.e6
  • [35] Concomitant triptan and SSRI or SNRI use: What is the risk for serotonin syndrome?
    Evans, Randolph W.
    HEADACHE, 2008, 48 (04): : 639 - 640
  • [36] Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum
    Bonetto, N.
    Santelli, L.
    Battistin, L.
    Cagnin, A.
    CEPHALALGIA, 2007, 27 (12) : 1421 - 1423
  • [37] HEALTHCARE UTILIZATION AND COSTS OF SEROTONIN SYNDROME WITH CONCOMITANT USE OF SEROTONERGIC AGENTS
    Xie, L.
    Wang, Z.
    Alley, S.
    Baser, O.
    Nguyen, C.
    VALUE IN HEALTH, 2015, 18 (03) : A114 - A114
  • [38] Serotonin Toxicity Precipitated by Tramadol in the Setting of Polypharmacy: A Case of Serotonin Syndrome
    de Villa, Ariel Ruiz
    Jones, Tyler
    Lleshi, Amina
    Macahuachi, Monica
    Lamar, Katie
    Bazikian, Yvette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [40] Serotonin Syndrome Induced by Drug Interaction of Isoniazid and Metoclopramide
    Hwang, J.
    Shim, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199